NEW YORK, June 26, 2024 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced it has ...
Mesoblast (NASDAQ:MESO) added ~13% in the morning hours on Tuesday after the Australian biotech said that the FDA agreed with the company regarding key components of a marketing application (BLA) ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results